Table 1 Differences in the clinical features among those groups classified by NFS
From: The correlation between triiodothyronine and the severity of liver fibrosis
Parameters | Q1 | Q2 | Q3 | P values |
|---|---|---|---|---|
Number | 690 | 691 | 691 | Â |
Gender (Male, %) | 418(60.6%) | 424(61.4%) | 427(61.8%) | 0.896 |
Age (Year, Mean ± SD) | 46.75(12.96) | 55.67(11.45) | 64.72(10.61) | < 0.001 |
Hypertension (%) | 213(30.9%) | 292(42.2%) | 393(56.9%) | < 0.001 |
BMI (kg/M2, Mean ± SD) | 24.00(3.76) | 24.57(3.54) | 25.52(4.55) | < 0.001 |
Obesity (%) | 87(12.6%) | 105(15.2%) | 151(21.8%) | < 0.001 |
Duration (Year, Mean ± SD) | 7.60(2.16) | 7.95(3.91) | 8.36(2.97) | < 0.001 |
TSH (mIU/L, Mean ± SD) | 1.70(0.88) | 1.68(0.86) | 1.79(0.91) | 0.066 |
fT4 (pmol/L, Mean ± SD) | 17.37(2.17) | 16.65(2.17) | 16.16(2.12) | < 0.001 |
fT3 (pmol/L, Mean ± SD) | 4.71(0.56) | 4.57(0.50) | 4.46(0.49) | < 0.001 |